Novartis AG and Bayer AG are among nearly 30 drugmakers that have taken steps to raise the U.S. prices of their medicines in January, ending a self-declared halt to increases made by a pharma industry under pressure from the Trump administration, according to documents seen by Reuters.

from Reuters: Health News https://ift.tt/2Sc0Ut0
via IFTTT
from Reuters: Health News https://ift.tt/2Sc0Ut0
via IFTTT
Post a Comment